Kory Wentworth

Direttore Finanziario/CFO presso ENTRADA THERAPEUTICS, INC.

Patrimonio netto: 219 884 $ in data 30/04/2024

45 anni

Health Technology

Consumer Services

Posizioni attive di Kory Wentworth

Società	Posizione	Inizio	Fine
ENTRADA THERAPEUTICS, INC.	Direttore Finanziario/CFO	01/11/2020	-
ENTRADA THERAPEUTICS, INC.	Treasurer	01/11/2020	-

Società	Posizione	Inizio	Fine
BLUEBIRD BIO, INC.	Comptroller/Controller/Auditor	18/12/2017	08/09/2020
BLUEBIRD BIO, INC.	Treasurer	18/12/2017	02/10/2020
ALEXION PHARMACEUTICALS, INC.	Comptroller/Controller/Auditor	01/11/2017	01/12/2017
	Direttore/Membro del Consiglio	01/01/2012	01/12/2017
	Corporate Officer/Principal	01/12/2008	01/12/2017

Susquehanna University

Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Comptroller/Controller/Auditor	2
Treasurer	2
Undergraduate Degree	1

Settori

Health Technology	4
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
BLUEBIRD BIO, INC.	Health Technology
ENTRADA THERAPEUTICS, INC.	Health Technology

Aziende private	1
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology

Aziende private

Health Technology